Journal profile · Oncology
ONCOLOGIST
ISSN 1083-7159 · eISSN 1549-490X · AlphaMed Press · UNITED STATES · Monthly · Founded 1996
ONCOLOGIST: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 4.66; fully open access; APC about USD 3,852; median 110 days to acceptance (117 articles, last 24 months); community-reported acceptance: fairly hard; 575 articles in 2025; indexed in SCIE and Scopus; the journal's website says it has moved to a new publisher.
The journal's website says it has moved to a new publisher: As of January 2022, The Oncologist is no longer published by Wiley. Information and current content can be found on the new publisher's website here: https://academic.oup.com/oncolo Source ↗Publisher website ·
Scope
Aims, scope and focus
ONCOLOGIST is published by AlphaMed Press and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations and Colorectal Cancer Treatments and Studies, together about 21.1% of its articles. Its main subfields are Oncology. (generated from OpenAlex topic counts and CAS ranking data)
The Oncologist is committed to helping physicians excel in the constantly changing fields of oncology and hematology through the publication of timely reviews, original studies, and commentaries on important developments.
From the journal's Aims & Scope
Research area (LetPub): Oncology
Main research topics OpenAlex counts of recent articles; shares are approximate
- Cancer Immunotherapy and BiomarkersMedicine7.3%
- Lung Cancer Treatments and MutationsMedicine7.1%
- Colorectal Cancer Treatments and StudiesMedicine6.7%
- Cancer Treatment and PharmacologyMedicine6.1%
- Breast Cancer Treatment StudiesBiochemistry, Genetics and Molecular Biology5.8%
- HER2/EGFR in Cancer ResearchMedicine5.6%
- Cancer Genomics and DiagnosticsBiochemistry, Genetics and Molecular Biology5.6%
- Lung Cancer Research StudiesMedicine5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Oncology | Zone 2 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Oncology | Zone 2 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Oncology | Zone 2 |
Top journal: yesReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 4.66LetPub ·
- CiteScore 2026-06
- 6.8LetPub ·
- SJR 2026-06
- 1.96LetPub ·
- SNIP 2026-06
- 1.46LetPub ·
- h-index
- 145LetPub ·
- h-index
- 229OpenAlex ·
- i10-index
- 4,360OpenAlex ·
- 2-year mean citedness
- 3.26OpenAlex ·
- Self-citation rate
- 2.1%LetPub ·
- Share of gold OA articles
- 99.8%LetPub ·
Volume
- Articles per year
- 376LetPub ·
Articles by year OpenAlex count · 7,676 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 565 | 565 | 162 |
| 2025 | 575 | 575 | 1,531 |
| 2024 | 418 | 418 | 3,385 |
| 2023 | 377 | 377 | 4,701 |
| 2022 | 339 | 339 | 6,417 |
| 2021 | 347 | 331 | 8,677 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
110 daysMedian, submission to acceptance · P25–P75 66 days – 179 days
- Acceptance to online
- median 7 days (47 articles)
- Submission to online
- median 112 days
- Sample
- 117 articles with submission and acceptance dates (1,025 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 3–8 weeksLetPub ·
- Average acceptance (community reports)
- Fairly hardLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessOpenAlex
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,852 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- AlphaMed Press
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Monthly
- Founded
- 1996
- ISSN
- 1083-7159
- Electronic ISSN
- 1549-490X
- Latest issue on the website
- Volume 26, Issue 12 (December 2021)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about ONCOLOGIST
What CAS zone is ONCOLOGIST in?
In the 2025 upgraded edition of the CAS Journal Ranking, ONCOLOGIST is in Zone 2 of Medicine, and in Zone 2 of the minor category Oncology. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of ONCOLOGIST?
The latest impact factor listed by LetPub is 4.66; CiteScore 6.8, h-index 229.
How long does peer review take at ONCOLOGIST?
Based on the dates recorded on 117 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 110 days (interquartile range 66–179 days); authors report an average review time of 3–8 weeks; the community-reported acceptance is “Fairly hard”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index ONCOLOGIST?
According to LetPub and DOAJ records, ONCOLOGIST is indexed in SCIE, Scopus and DOAJ.
Is ONCOLOGIST open access, and what is the APC?
ONCOLOGIST is a fully open-access journal. APC about USD 3,852.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .